source
- STAT+: Supreme Court rejects challenge to Medicare drug price negotiationThe rejection may make the pharma firms remaining lawsuits more difficult.STAT · 2mo ago↗ source
- STAT+: Pharmalittle: We’re reading about U.S. biotech’s China problem, a Regeneron flop, and much moreThe question of whether to partner with Chinese firms — or see them as rivals — is tearing biotech apart, pitting peers and partners against one anotherSTAT · 2mo ago↗ source
- Texas is opening up a detransition clinicAmericans exposed to Ebola outbreak, Bill Cassidy's primary defeat, and more health news from Morning RoundsSTAT · 2mo ago↗ source